Analysis RHÖN-KLINIKUM Aktiengesellschaft (0NQH)
5/30/2024
Analysis of RHÖN-KLINIKUM Aktiengesellschaft (0NQH)
RHÖN-KLINIKUM Aktiengesellschaft is showing some interesting technical indicators based on the provided data:1. RSI (Relative Strength Index) is around 36.12, indicating that the stock is not currently in the overbought or oversold territory. It suggests a neutral position.
2. MACD (Moving Average Convergence Divergence) is positive at 0.24, but the MACD line is below the signal line, which might indicate a potential bearish signal.
3. The stock's closing price has been consistent around 12.15 in the recent days.
4. The Moving Average (MA) indicator is at 12.69, which is higher than the current closing price, suggesting a potential upward trend.
Overall, based on the technical indicators, RHÖN-KLINIKUM Aktiengesellschaft seems to be in a neutral position with some mixed signals. Traders and investors might want to monitor the stock closely for any potential changes in the trend.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest that the company has experienced significant growth in the past but is expected to see a more moderate growth rate in the coming years. The next year is expected to show a higher growth rate compared to the current year, and the next 5 years are projected to have a growth rate lower than the average of the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price of the security is $191.57, which is below the median and average forecast, indicating that some analysts expect the price to increase in the future.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided yet. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results for January 31, 2025, were released after hours. The results for October 31, 2024, were not provided at the specified time. However, the results for August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic 🧠
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.
Moving on to stock statistics, key metrics include short ratio, float shares, shares outstanding, and percentages held by insiders and institutions. The company's stock price summary provides information on beta, moving averages, and the range of the stock price over the past year.
Valuations metrics show metrics such as P/E ratios, enterprise value, price to book, and price to sales ratios. These metrics help in evaluating the company's valuation in the market.
Lastly, dividends and splits information includes details on dividend rates, payout ratios, dividend dates, and historical split factors. This information is important for investors interested in the company's dividend policy and history.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential decrease in profit margins.
3. The company's gross profit has fluctuated over the years, reaching its peak in 2023 at $169.1 billion.
4. Operating income has shown an upward trend, with the company generating $114.3 billion in 2023 compared to $66.3 billion in 2020.
5. Net income has also been increasing annually, reaching $97 billion in 2023 from $57.4 billion in 2020.
6. Earnings per share (EPS) have shown a slight variation but have generally been on an upward trajectory.
7. The company has been able to maintain a stable number of outstanding shares over the years.
8. Overall, the financial performance of the company in terms of revenue and income has been positive, with consistent growth in sales and profitability.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive outlook with an increase in earnings per share expected for both the next quarter and the next year compared to the previous periods. The number of analysts providing estimates also indicates a strong interest in the company's performance.
MACD of 0NQH
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
